Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
6.33
+0.26 (4.28%)
At close: May 4, 2026, 4:00 PM EDT
6.33
0.00 (0.00%)
After-hours: May 4, 2026, 4:10 PM EDT
Minerva Neurosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
277.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cellectis | 79.59M |
| Compugen | 72.76M |
| Coherus Oncology | 42.17M |
| Foghorn Therapeutics | 30.91M |
| Alector | 21.05M |
| LENZ Therapeutics | 19.09M |
| Adagene | 7.67M |
| Artiva Biotherapeutics | 251.00K |
NERV News
- 4 weeks ago - Minerva Announces Leadership Transition - GlobeNewsWire
- 4 weeks ago - Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia - GlobeNewsWire
- 5 weeks ago - Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026 - GlobeNewsWire
- 6 weeks ago - Minerva Neurosciences Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 7 weeks ago - Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum - GlobeNewsWire
- 7 weeks ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates - GlobeNewsWire
- 7 weeks ago - Minerva Neurosciences Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 2 months ago - Minerva Neurosciences to Participate in The Citizens Life Sciences Conference - GlobeNewsWire